These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 8328738)

  • 1. Renal mechanism of trimethoprim-induced hyperkalemia.
    Velázquez H; Perazella MA; Wright FS; Ellison DH
    Ann Intern Med; 1993 Aug; 119(4):296-301. PubMed ID: 8328738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimethoprim-sulfamethoxazole induces reversible hyperkalemia.
    Greenberg S; Reiser IW; Chou SY; Porush JG
    Ann Intern Med; 1993 Aug; 119(4):291-5. PubMed ID: 8328737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperkalemia with high-dose trimethoprim-sulfamethoxazole therapy.
    Greenberg S; Reiser IW; Chou SY
    Am J Kidney Dis; 1993 Oct; 22(4):603-6. PubMed ID: 8213804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mechanism for pentamidine-induced hyperkalemia: inhibition of distal nephron sodium transport.
    Kleyman TR; Roberts C; Ling BN
    Ann Intern Med; 1995 Jan; 122(2):103-6. PubMed ID: 7992983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethoprim-sulfamethoxazole: hyperkalemia is an important complication regardless of dose.
    Perazella MA; Mahnensmith RL
    Clin Nephrol; 1996 Sep; 46(3):187-92. PubMed ID: 8879854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimethoprim-sulfamethoxazole therapy in outpatients: is hyperkalemia a significant problem?
    Alappan R; Buller GK; Perazella MA
    Am J Nephrol; 1999; 19(3):389-94. PubMed ID: 10393376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole.
    Alappan R; Perazella MA; Buller GK
    Ann Intern Med; 1996 Feb; 124(3):316-20. PubMed ID: 8554227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of trimethoprim on serum creatinine, sodium, and potassium concentrations in patients taking trimethoprim-sulfamethoxazole without changes in glomerular filtration rate.
    Yokoyama S; Nakagawa J; Aiuchi N; Seito T; Niioka T
    J Clin Pharm Ther; 2022 Sep; 47(9):1409-1417. PubMed ID: 35545234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of trimethoprim-induced antikaliuresis.
    Reiser IW; Chou SY; Brown MI; Porush JG
    Kidney Int; 1996 Dec; 50(6):2063-9. PubMed ID: 8943491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperkalemia and high-dose trimethoprim/sulfamethoxazole.
    Hsu I; Wordell CJ
    Ann Pharmacother; 1995 Apr; 29(4):427-9. PubMed ID: 7633023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mineralocorticoid-resistant renal hyperkalemia without salt wasting (type II pseudohypoaldosteronism): role of increased renal chloride reabsorption.
    Schambelan M; Sebastian A; Rector FC
    Kidney Int; 1981 May; 19(5):716-27. PubMed ID: 7026872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. University of Miami Division of Clinical Pharmacology therapeutic rounds: drug-induced hyperkalemia.
    Preston RA; Hirsh MJ MD; Oster MD; Oster HR MD
    Am J Ther; 1998 Mar; 5(2):125-32. PubMed ID: 10099101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential acute effects of aldosterone, dexamethasone, and hyperkalemia on distal tubular potassium secretion in the rat kidney.
    Field MJ; Stanton BA; Giebisch GH
    J Clin Invest; 1984 Nov; 74(5):1792-802. PubMed ID: 6501571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief report: trimethoprim-induced hyperkalemia in a patient with AIDS.
    Choi MJ; Fernandez PC; Patnaik A; Coupaye-Gerard B; D'Andrea D; Szerlip H; Kleyman TR
    N Engl J Med; 1993 Mar; 328(10):703-6. PubMed ID: 8433730
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the mechanism of trimethoprim-induced hyperkalemia.
    Eiam-Ong S; Kurtzman NA; Sabatini S
    Kidney Int; 1996 May; 49(5):1372-8. PubMed ID: 8731102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A micropuncture study of potassium excretion by the remnant kidney.
    Bank N; Aynedjian HS
    J Clin Invest; 1973 Jun; 52(6):1480-90. PubMed ID: 4703232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimethoprim-induced hyperkalaemia: clinical data, mechanism, prevention and management.
    Perazella MA
    Drug Saf; 2000 Mar; 22(3):227-36. PubMed ID: 10738846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudohypoaldosteronism type II: proximal renal tubular acidosis and dDAVP-sensitive renal hyperkalemia.
    Nahum H; Paillard M; Prigent A; Leviel F; Bichara M; Gardin JP; Idatte JM
    Am J Nephrol; 1986; 6(4):253-62. PubMed ID: 3777034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimethoprim-associated hyponatremia.
    Babayev R; Terner S; Chandra S; Radhakrishnan J; Mohan S
    Am J Kidney Dis; 2013 Dec; 62(6):1188-92. PubMed ID: 23891358
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.